Racho Ronald G, Krishna Murli, Coe Susan G, Thomas Colleen S, Crook Julia E, Diehl Nancy N, Wallace Michael B
Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Department of Gastroenterology, University of Kentucky College of Medicine, Lexington, KY, USA.
Dig Dis Sci. 2017 Jun;62(6):1464-1471. doi: 10.1007/s10620-017-4582-2. Epub 2017 Apr 25.
Sessile serrated adenomas/polyps (SSA/P) are an under-recognized disease with a unique malignant pathway. Improved endoscopic recognition and pathological interpretation is needed.
To determine whether an educational intervention that improved adenoma detection rate (ADR) could improve SSA/P detection rate after reclassification of previously termed "hyperplastic" polyps.
We reanalyzed data from a prospective randomized trial of an educational intervention aimed at increasing ADR. All hyperplastic polyps ≥6 mm reported in a previously published study were rereviewed and reclassified using standardized criteria for serrated lesions. Detection rates of sessile serrated adenomas/polyps and other clinically relevant serrated polyps were calculated in the baseline and post-training phases of the original study.
Of 263 available for rereview, 33 (12.5%) were reclassified as SSA/P (N = 32) or traditional serrated adenoma (TSA) (N = 1). Reclassification was more common in the right colon (18 vs. 8%, p = 0.02). Baseline SSA/P detection rate was 0.7% in the untrained group and 1.3% in the trained group. Post-training, the SSA/P detection rate increased to 2.1 and 1.5%, respectively. The clinically relevant serrated polyp detection rate at baseline was 14.2% in the untrained group and 11.3% in the trained group. After the educational intervention, the clinically relevant serrated polyp detection rates increased to 16.5 and 14.8% in the untrained and trained groups, respectively. The estimated odds of an endoscopist detecting either a SSA/P or other clinically relevant serrated polyp during colonoscopy increased by only 3% with the educational intervention (OR 1.03, 95% CI 0.61-1.74, p = 0.91).
Pathological re-interpretation of larger serrated polyps resulted in the reclassification of 12.5% of lesions. Quality improvement methods focused on adenoma detection did not impact SSA/P detection, and thus specific methods for serrated polyp detection are needed.
无蒂锯齿状腺瘤/息肉(SSA/P)是一种认识不足的疾病,具有独特的恶性发展途径。需要提高内镜识别能力和病理诊断水平。
确定一项提高腺瘤检出率(ADR)的教育干预措施,在对先前称为“增生性”息肉重新分类后,是否能提高SSA/P的检出率。
我们重新分析了一项旨在提高ADR的教育干预前瞻性随机试验的数据。对先前发表的一项研究中报告的所有直径≥6毫米的增生性息肉,使用锯齿状病变的标准化标准进行重新评估和重新分类。在原始研究的基线期和培训后阶段,计算无蒂锯齿状腺瘤/息肉和其他临床相关锯齿状息肉的检出率。
在可供重新评估的263个病例中,33个(12.5%)被重新分类为SSA/P(n = 32)或传统锯齿状腺瘤(TSA)(n = 1)。重新分类在右半结肠更为常见(18%对8%,p = 0.02)。未培训组的基线SSA/P检出率为0.7%,培训组为1.3%。培训后,SSA/P检出率分别提高到2.1%和1.5%。未培训组基线时临床相关锯齿状息肉检出率为14.2%,培训组为11.3%。教育干预后,未培训组和培训组临床相关锯齿状息肉检出率分别提高到16.5%和14.8%。教育干预使结肠镜检查时内镜医师检测到SSA/P或其他临床相关锯齿状息肉的估计几率仅增加了3%(比值比1.03,95%置信区间0.61 - 1.74,p = 0.91)。
对较大锯齿状息肉进行病理重新评估导致12.5%的病变重新分类。专注于腺瘤检测的质量改进方法并未影响SSA/P的检测,因此需要针对锯齿状息肉检测的特定方法。